PTPRC and neoplasm: We then characterized the dynamics of the immune-cell landscape during tumor progression by performing scRNA-seq on isolated CD45+ cells of five pooled tumor tissues obtained from early stage and late-stage (days 15 and 25, respectively) SC and BOT models.